October 30, 2015
Article
Choosing a treatment based on data can be fraught with challenges, but it can make all the difference.
Optune Plus Temodar and Keytruda May Result in Brain Tumor Control
ICI Response May Predict Relapse-Free Survival in Liver Cancer
Taking Time to ‘Smell the Roses’
Addressing Pros and Cons of CAR-T Cell Therapy in Melanoma